Hong Kong Stocks Extend Gains Despite China's GDP Miss; Insilico Medicine Climbs

MT Newswires Live07-15 16:41

Hong Kong stocks held their momentum Wednesday as stronger-than-expected Chinese industrial output and retail sales data offset concerns over the country's weakest quarterly economic growth in more than three years.

The Hang Seng Index rose 1.4%, or 340.37 points, to close at 24,681.10, while the Hang Seng China Enterprises Index gained 1%, or 81.30 points, to finish at 8,184.38.

China's economy expanded 4.3% year over year in the second quarter, slowing from 5% in the previous quarter and marking its weakest pace of growth since the fourth quarter of 2022.

However, June industrial output rose 5.3% from a year earlier, and retail sales increased 1%, with both figures exceeding analysts' expectations, suggesting resilience in economic activity.

In corporate news, Insilico Medicine (HKG:3696) advanced over 10% after entering a strategic alliance with Bora Pharmaceuticals (TPE:6472) to collaborate on AI-driven drug discovery and development.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment